CUMYL-THPINACA
From Wikipedia, the free encyclopedia
 |
|
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
|
|
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C23H27N3O2 |
| Molar mass | 377.5 g/mol |
| 3D model (Jmol) | |
|
|
|
|
CUMYL-THPINACA (also known as SGT-42) is an indazole-3-carboxamide based synthetic cannabinoid.[1] CUMYL-THPINACA acts as a potent agonist for the cannabinoid receptors, with approximately 6x selectivity for CB1, having an EC50 of 0.1nM for human CB1 receptors and 0.59nM for human CB2 receptors.[2]
Legal status[edit]
Sweden's public health agency suggested to classify CUMYL-THPINACA as hazardous substance on November 10, 2014.[3]
As of October 2015 CUMYL-THPINACA is a controlled substance in China.[4]
See also[edit]
References[edit]
- ^ "CUMYL-THPINACA". Cayman Chemical. Retrieved 11 July 2015.
- ^ Bowden; et al. (11 April 2013). "Patent WO 2014167530 - Cannabinoid compounds". New Zealand Patent application 623626. Retrieved 11 July 2015.
- ^ "Cannabinoider föreslås bli klassade som hälsofarlig vara". Retrieved 11 July 2015.
- ^ "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Retrieved 1 October 2015.
 |
This cannabinoid related article is a stub. You can help Wikipedia by expanding it. |
